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Summary
 
B lymphocytes undergo affinity maturation of their antigen receptors within germinal centers.
These anatomical structures develop in secondary lymphoid organs from the clonal expansion
of a few antigen-specific founder B cells, whose isolation and characterization are reported
here. Human germinal center founder cells express the naive B cell markers surface IgM and
IgD as well as the germinal center B cell markers CD10 and CD38. They express low levels of
Bcl-2, high levels of Fas, and undergo rapid apoptosis in culture. The smaller nonproliferating
sIgM
 
1
 
IgD
 
1
 
CD38
 
1
 
 B cells displayed a lower level of somatic mutation in their immunoglobulin
variable region genes compared with the large proliferating ones. Unmutated sIgM
 
1
 
IgD
 
1
 
CD38
 
1
 
tonsillar B cells may thus represent germinal center founder cells in which the program for apoptotic
cell death is triggered before the onset of somatic mutation, allowing the selection of the germ-
line antibody repertoire at an early stage.
 
T
 
he T cell–dependent primary humoral responses are
initiated by the activation of sIgM
 
1
 
IgD
 
1
 
 naive B cells
in the T cell–rich foci of secondary lymphoid tissues (1–4),
allowing the generation of short-lived plasma cells and the
recruitment of germinal center (GC)
 
1
 
 founder cells into B
cell follicles (1–4). These cells undergo clonal expansion,
somatic mutation of their IgV genes (5–11), and antigen-
driven affinity maturation (12–20). The maturation path-
way of peripheral B lymphocytes during T cell–dependent
immune response can be traced by changes of surface mol-
ecule expression (21). Accordingly, we have previously re-
ported the purification and characterization of five human
tonsillar B cell subpopulations: Bm1 and Bm2 are two sub-
sets of follicular mantle B cells which are sIgD
 
1
 
CD38
 
2
 
CD23
 
2
 
 and sIgD
 
1
 
CD38
 
2
 
CD23
 
1
 
, respectively; Bm3 and
Bm4 represent sIgD
 
2
 
CD38
 
1
 
CD77
 
1
 
 GC centroblasts and
sIgD
 
2
 
CD38
 
1
 
CD77
 
2
 
 centrocytes, respectively; and Bm5
represents sIgD
 
2
 
CD38
 
2
 
 memory B cells (11, 22–25).
However, B cells corresponding to the transition stage
from naive follicular mantle B cells to GC B cells have not
been characterized yet. Recently, we have identified tonsil-
lar B cells that coexpress sIgD and CD38, and that can be
further separated into sIgM
 
1
 
 and sIgM
 
2
 
 subsets. Sequence
analysis of IgV genes shows that the sIgM
 
2
 
IgD
 
1
 
CD38
 
1
 
subset contains extensively mutated IgV genes, excluding
the possibility that they could be GC founder cells (26).
Here we present the evidence that the sIgM
 
1
 
IgD
 
1
 
CD38
 
1
 
subset contains medium sized nonproliferating GC founder
cells that acquire the propensity to undergo apoptosis be-
fore the onset of somatic mutation.
 
Materials and Methods
 
Antibodies.
 
Antibodies (clone number, isotype, and source)
used for phenotyping and immunomagnetic bead depletion are
listed in Table 1.
 
Isolation of Tonsillar B Cells.
 
Tonsillar B cells were prepared as
previously described (25). Briefly, tonsils taken from patients dur-
ing routine tonsillectomy were finely minced and the resulting
cell suspension was subjected to two rounds of depletion of non-B
cells: (
 
a
 
) T cells were depleted by rosetting with sheep red blood
cells, (
 
b
 
) residual non-B cells were depleted by T cell specific an-
tibodies (CD2, CD3, and CD4), and then by magnetic beads
coupled with anti–mouse IgG (Dynabeads; Dynal, Oslo, Norway).
The resulting cells from all the experiments contained 
 
.
 
98%
CD19 positive B cells.
 
Phenotype Analysis of the Four B Cell Subsets Defined by the Ex-
pression of sIgD and sCD38 by Three-color Immunofluorescence Flow
Cytometry.
 
Total tonsillar B cells were incubated with mouse
anti–human CD38-PE, goat anti–human IgD-biotin, and a set of
FITC-conjugated mouse anti–human IgM, CD23, CD44, CD10,
CD71, CD77, and Fas/CD95 for 20 min at 4
 
8
 
C. After washing
twice with PBS containing 2% BSA, cells were incubated with
streptavidin-tricolor for 30 min and analyzed with a FACScan
 
Ò
 
flow cytometer. For intracellular Bcl-2 and nuclear Ki67 staining,
cells were permeabilized by incubation with 3 g/100 ml saponin
for 15 min at 4
 
8
 
C.
 
Separation of IgD
 
1
 
CD38
 
1
 
 Tonsillar B Cells into IgM
 
1
 
 and IgM
 
2
 
Subsets by Three-color Immunofluorescence FACS
 
Ò
 
 Sorting.
 
Total ton-
sillar B cells were incubated with mouse anti–human CD38-PE and
 
1
 
Abbreviations used in this paper:
 
 APAAP, alkaline phosphatase-anti-alkaline
phosphatase system; GC, germinal center.
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goat anti–human IgD-biotin for 20 min at 4
 
8
 
C. After washing
twice with PBS containing 2% BSA, the cells were incubated with
mouse anti–human IgM-FITC and streptavidin-tricolor for 20
min. Then cells were washed twice and suspended in PBS at a con-
centration of 3 
 
3
 
 10
 
6
 
/ml. IgD
 
1
 
CD38
 
1
 
 B cells were separated into
two subsets according to the expression of sIgM on a FACStar plus
 
Ò
 
.
IgM
 
1
 
IgD
 
1
 
CD38
 
1
 
 B cells from one tonsil were further size frac-
tionated according to their forward scatter parameters.
 
Giemsa Staining and Analysis of Nuclear Antigen Ki67.
 
10
 
5
 
 cells
from each of the purified B cell subsets were cytocentrifuged for
5 min at 500 rpm on a microscope slide. Slides were fixed in
methanol for 5 min and then stained with Giemsa staining solu-
tion (BDH Chemicals Ltd., Poole, England) diluted one in five
with distilled water. Some slides were fixed in cold acetone at
4
 
8
 
C for 10 min for immunocytology. Slides were washed in PBS
for 5 min and incubated with mouse mAb against Ki67 antigen
(DAKO, Glostrup, Denmark) for 45 min. The slides were
washed twice in PBS and then incubated with sheep anti–mouse
Ig (The Binding Site, Birmingham, England). After 45 min, slides
were washed and incubated with mouse mAb against alkaline
 
Table 1.
 
Antibody List
 
Anti–human Abs Clone Isotype Source
CD 2 (FITC) 39 C1.5 IgG2a (rat) Immunotech (Marseille, France)
CD 3 (FITC) UCHT 1 IgG1 Immunotech
CD 10-FITC W8 E37 IgG2a Becton Dickinson (Mountain View, CA)
CD 14-FITC RMO 52 IgG2a Immunotech
CD 19-FITC J4-119 IgG1 Immunotech
CD 20-FITC IOB 20b IgG1 Immunotech
CD 23-PE B-G6 IgG1 Serotec Ltd. (Oxford, UK)
CD 38 T 10 IgG1 Immunotech
CD 38-PE HB-7 IgG1 Becton Dickinson
CD 39 (Biot.) Ac-2 IgG1 The Binding Site (Birmingham, UK)
CD 44-FITC NaM 10-8F4 IgG1 Diagast (Lille, France)
CD 71-FITC IOA 71 IgG1 Immunotech
CD 77 sup. 38-13 IgM (rat) Immunotech
Fas-FITC UB 2 IgG1 Immunotech
FAS CH 11 IgM Immunotech
Bcl2-FITC IgG1 DAKO (Glostrup, Denmark)
Ki67-FITC IgG1 DAKO
IgM-FITC F(ab
 
9
 
)2 (rabbit) DAKO
Ig D Biot. IgG (goat) Amersham Intl. (Buckinghamshire, UK)
Ig A pur. IgG1 Serotec Ltd.
Ig G pur. IgG1 Serotec Ltd.
Secondary Abs
Goat anti–mouse-FITC IgG 
 
1
 
 IgM Bioart (Neudon, France)
Goat anti–rat-FITC IgM Nordic Immunological Labs. (Tilburg, The Netherlands)
Streptavidin-PE Becton Dickinson
Streptavidin-FITC Immunotech
Streptavidin-Tricolor CALTAG Labs. (South San Francisco, CA)
Ig isotype controls
Mouse IgG1 Biot. CALTAG Labs.
Mouse IgM Immunotech
Rat IgG2a FITC Immunotech
Mouse Ig G1 FITC/PE Immunotech
Mouse Ig G2A FITC/PE Immunotech
Immunochemistry reagents
Ig D Biot. IgG (goat) Amersham Intl.
IgM 145-8 IgGl Becton Dickinson
Streptavidin-peroxydase DAKO
APAAP DAKO 
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phosphatase and alkaline phosphatase complexes (APAAP) (DAKO).
After an additional 45 min, the slides were washed three times in
PBS and the enzyme activity was developed by the FAST RED
substrate (DAKO).
 
Cell Cultures.
 
Cells were cultured in RPMI 1640 medium
containing 10% heat inactivated fetal calf serum, 80 
 
m
 
g/ml gen-
tamicin, and 2 mM glutamine (all from Flow Laboratories, Inc.,
MacLean, VA) at 37
 
8
 
C. Cells (2.5 
 
3
 
 10
 
5
 
/ml) were cultured for 5 d
in one of the following conditions: IL-2 (10 U/ml), IL-4 (50 U/ml),
or IL-10 (100 ng/ml). 2.5 
 
3
 
 10
 
4
 
 CD40-ligand transfected L cells
and 2.5 
 
3
 
 10
 
3
 
 human fibroblasts from rheumatoid synovium (ir-
radiated with 75Gy) were used for the cultures. DNA synthesis
was assessed by an 8 h pulse with 1 
 
m
 
Ci [
 
3
 
H]TdR before cell har-
vesting.
 
Immunohistology.
 
Portions of tonsils were snap frozen in liq-
uid nitrogen and stored at 
 
2
 
70
 
8
 
C. 5 
 
m
 
m frozen sections were cut
and mounted on glass slides. They were thoroughly dried at room
temperature for 
 
$
 
1 h and were fixed in acetone at 4
 
8
 
C for 15
min. Sections were stained by double immunoenzyme technique
using biotin-avidin-peroxidase system and alkaline phosphatase-
anti-alkaline phosphatase system (APAAP technique). Briefly,
sections were washed in PBS for 5 min. Then sections were incu-
bated with goat anti–human IgD-biotin and mouse anti–human
IgM (IgG1 isotype). After washing for 5 min in PBS, the sections
were incubated with streptavidine-peroxidase and sheep anti–
mouse IgG1 for 30 min, and then incubated with alkaline phos-
phatase coupled to mouse antibodies specific for alkaline phos-
phatase (APAAP complexes). After a final wash, peroxidase was
developed by 3-amino-9-ethylcarbazole which gives a red color,
and alkaline phosphatase was developed by Fast blue substrate
which gives a blue color (27).
 
Analysis of the VH5 Transcripts PCR Amplified from the Human B
Cell Subsets.
 
mRNA was extracted from 25 
 
3
 
 10
 
3
 
 B cells (11).
cDNA was obtained by reverse transcription using the Superscript
Reverse Transcriptase Kit (GIBCO BRL, Gaithersburg, MD),
with oligo dT
 
12
 
 
 
–18
 
 primers (Pharmacia, Upsalla, Sweden). Full
length VH5 transcripts were amplified with L-VH5 primer
(5
 
9
 
CCCGAATTCATGGGGTCAACCGCCATCCT3
 
9
 
) with 3
 
9
 
primer CH
 
m
 
 (TGGGGCGGATGCACTCCC) with Taq poly-
merase (Perkin-Elmer Corp., Norwalk, CT) using the reaction
buffer provided by the manufacturers and a DNA thermal cycler
(Perkin-Elmer Corp.) with 35 cycles of 1 min denaturation at
94
 
8
 
C, 2 min of primer annealing at 60
 
8
 
C, and 3 min extension at
72
 
8
 
C. After the last cycle, the reaction mixtures were incubated
for 10 min at 72
 
8
 
C to ensure complete extension of all products.
The PCR products were cloned in PCR
 
Ô
 
II vector, using the
TA Cloning Kit (Invitrogen, San Diego, CA). Both DNA strands
of plasmids extracted from individual bacterial colonies were se-
quenced on an automated DNA sequencer (Applied Biosystems
Inc., Foster City, CA). Sequencing was done with the 
 
2
 
21M13
and M13RP primers flanking the plasmid cloning sites, and with
the CH
 
m
 
 primer annealing with the 3
 
9
 
 end of CH1-
 
m
 
.
 
Results
 
Three-color Flow Cytometry Identifies IgM
 
1
 
IgD
 
1
 
CD38
 
1
 
Tonsillar B Cells.
 
Human tonsillar B cells that coexpress
sIgD and CD38 have been identified, which represent 5–15%
of total human tonsillar B cells (Fig. 1 
 
A
 
). Three-color flow
cytometry shows that sIgD
 
1
 
CD38
 
1
 
 B cells express low
levels of the naive B cell markers CD23, CD44, and IgM,
while they express high levels of the germinal center mark-
ers CD71, CD10, and CD77 (Fig. 1 
 
B
 
). Unlike the
sIgD
 
1
 
CD38
 
2
 
 naive B cells, they express low levels of Bcl-2,
high levels of Fas, and many of them express the prolifera-
tion associated nuclear antigen Ki67 (Fig. 1 
 
B
 
). The
sIgD
 
1
 
CD38
 
1
 
 B cells were sorted into a sIgM
 
1
 
 subset (3–9%
of total tonsillar B cells) and a sIgM
 
2
 
 subset (2–6% of total
tonsillar B cells) (Fig. 1 
 
C
 
). Our recent study has shown
that sIgM
 
2
 
IgD
 
1
 
CD381 B cells represent a peculiar popula-
tion of highly mutated GC centroblasts (28). We have now
further characterized the sIgM1IgD1CD381 B cell subset
which displays a phenotype intermediate between follicular
mantle naive B cells and GC B cells.
sIgM1IgD1CD381 B Cells Display GC B Cell Morphol-
ogy, Propensity for Apoptosis, and Reduced Proliferation Capacity
In Vitro. Unlike small dense sIgM1sIgD1CD382 naive B
cells, sIgM1IgD1CD381 B cells are large- or medium-sized
lymphocytes, similar to IgD2CD381 GC B cells (12, 23).
Large IgM1IgD1CD381 B cells, which account for 20–
30% of the IgM1IgD1CD381 B cells, express the prolifera-
Figure 1. Subpopulations of tonsillar B cells. (A) Double staining of to-
tal tonsil B cells with anti–IgD-PE and anti–CD38-FITC, showing four
B cell subsets. The sIgD1CD381 B cells represent 5–15% of total tonsil
B cells from three representative samples. (B) Phenotypic analysis by three-
color flow cytometry. Anti–IgD-tricolor and anti–CD38-PE are used to-
gether with other third antibodies directly conjugated with FITC. Anti–
IgD-PE and anti–CD38-FITC were used together with Hoechst 33342.
For Bcl-2 and Ki67 staining, the cells were permeabilized by saponin
(0.33 g/100 ml in PBS, 1% BSA) for 15 min on ice. (C) Cell sorting of
sIgD1CD381 B cells into sIgM1 and sIgM2 subsets.566 Germinal Center Founder Cells
tion associated nuclear antigen Ki67, while medium-sized
IgM1IgD1CD381 B cells are Ki672 (Fig. 2 B). Like
IgD2CD381 GC B cells, .90% of IgM1IgD1CD381 B
cells display apoptotic figures after 16 h of culture (Fig. 2 C
and Table 2). The survival and proliferation of IgM1
IgD1CD381 B cells in vitro depend on the presence of
CD40-ligand and T cell cytokines such as IL-2, -4, and -10
(Table 3). The level of DNA synthesis observed under identi-
cal culture conditions is always lower in IgM1IgD1CD381
B cells than in IgD1CD382 naive B cells, but higher than
in IgD2CD381 GC B cells (Table 3).
Somatic Mutation Has Occurred in a Fraction of sIgM1IgD1
CD381 B Cells. VH5-m sequence analysis has been suc-
cessfully used to trace the progression of human tonsillar B
cell subsets from the virgin to the memory compartment
(11). Therefore, 32 VH5-m sequences from sIgM1IgD1
CD381 B cells were compared to 30 VH5-m sequences
from sIgM1IgD1CD382 naive B cells of three tonsil sam-
ples (Fig. 3, A and B). In agreement with our previous re-
ports, all 30 sequences from naive B cells contain 0–2 mu-
tations per sequence, with an overall mutation frequency of
2 3 1023 bp (20 mutations/9,600 bp) that is barely distin-
guishable from the PCR Taq-error rate (1 3 1023 bp).
Within 32 sequences from sIgM1IgD1CD381 B cells,
while 17 might be considered germline (0–2 mutations/se-
quence), 15 have accumulated from 3–13 mutations, with
an average mutation frequency of 20 3 1023 bp (88 muta-
tions/4,480 bp). The replacement mutations in 12 less mu-
tated sequences (3.2, 3.4, 3.10, 3.14, 3b.5, 3b.6, 3b.9,
3b.13, 3c.5, 3c.7, 3c.9, and 3c.12) are randomly distributed
within the CDRs and FWs, an indication of the absence of
antigen-driven selection. In contrast, sequences 3.11, 3b.7,
and 3c.6, which have accumulated 10–13 mutations, showed
replacement mutations mainly focused in the CDRs, sug-
gesting that these cells have undergone antigen-driven se-
lection. Unlike the VH5-g sequences from sIgD2CD381
GC B cells and VH5-d sequences from sIgM2IgD1CD381
reported previously (11, 28), no clonal relatedness could be
found among the VH5-m transcripts from tonsillar sIgM1
IgD1CD381 B cells. To establish whether the medium-
sized nonproliferating cells from this population are those
with unmutated V regions, sIgM1IgD1CD381 B cells were
isolated from a fourth tonsil and fractionated according to
their size. The subset of medium-sized sIgM1IgD1CD381
B cells was enriched for unmutated B cells (Fig. 3, C and D)
as five out of nine sequences from the medium-sized B
cells displayed less than two mutations and were therefore
considered as nonmutated. In contrast, only one out of
nine sequences from the large B cells was unmutated. In
those two subsets, the most mutated sequences show fea-
tures of antigen-driven selection.
IgM1IgD1 B Cells Can Be Found Within GC. It has been
previously reported that a small proportion of human GC
contain IgD1 B cells (29, 30). Indeed, by double immuno-
histological staining, we have recently confirmed these ob-
servations and further shown that IgD1 B cells within GC
display CD38, the majority of them expressing the prolifer-
ation associated nuclear antigen Ki67 (28). To distinguish
IgM1IgD1CD381 GC founder cells from highly mutated
IgM2IgD1CD381 GC B cells in situ (26), double staining
with anti-IgM and anti-IgD were performed on tonsil sec-
tions. While numerous large IgM2IgD1 B blasts were found
to be packed within occasional GC dark zones (26), only
scattered IgM1IgD1 B cells were found throughout a few
GCs (Fig. 4).
Discussion
During T cell–dependent primary immune responses,
antigen-specific naive B lymphocytes undergo either plasma
cell reaction in the T cell zones or enter into the B cell fol-
licles to initiate GC reaction. One of the questions regard-
ing GC development has been the identity of GC precur-
sor cells (16, 31, 32). Progress has been made by analyzing
the capacity of B cell subsets to form GC in the host ani-
mals after adoptive cell transfer and immunization. SCID
mice immunized after repopulation with carrier-primed
CD41 T cells and J11Dlow splenic B cells developed many
GC in their spleens. In contrast, when J11Dhigh cells or
CD51 peritoneal B cells were transferred, few, if any, GC
were generated (33). However, thoracic duct B cell transfer
experiments in rats have generated contradictory conclu-
sions as to whether GC precursor cells are sIgD1 or sIgD2
(34, 35). The present identification of tonsillar sIgM1IgD1
CD381 B cells represents a parallel attempt in the human
system to characterize GC founder cells.
The formal identification of GC founder cells would re-
quire the demonstration of a precursor–progeny relation-
Table 2. Percentage of Apoptotic Cells in B Cell Subsets
After a 16 h Culture
sIgD1CD382
Naive B
sIgD2CD381
GC B
sIgM1IgD1CD381
GC founder
Experiment 1 22 80 98
Experiment 2 8 78 92
Table 3. DNA Synthesis in Three B Cell Subsets at Day 5
of Culture
CD 40-ligand
CD40-ligand
IL-2 1 IL-10
CD40-ligand
IL-4 1 IL-10
sIgD1CD382 18,550 6 1,590 32,870 6 2,140 25,900 6 2,830
sIgM1IgD1
 CD381 570 6 160 8,610 6 160 18,350 6 2,720
sIgD2CD381 1,340 6 330 8,270 6 730 6,220 6 460
[3H]Thymidine uptake is expressed as cpm 6 SD. It represents one of
six identical experiments.567 Lebecque et al.
ship between such cells and GC mutated B cells. However,
we could not find clonally related unmutated sIgM1sIgD1
CD381 B cells and mutated sIgD2CD381 B cells from the
same tonsil within a limited number of sequences (data not
shown). In agreement with our results, when GC B cells
were individually picked from the same GC on human
lymph node tissue sections, no clonal relatedness could be
observed between the germline VH/Vk sequences and the
mutated sequences (8). It suggests that it might be difficult
to directly illustrate such a precursor-progeny relationship
in humans, since kinetic analysis is not easy to perform.
However, several important features suggest that medium-
sized nonproliferating sIgM1IgD1CD381 B cells might be
enriched for GC founder cells. First, these sIgM1IgD1 B cells
coexpress, albeit at a reduced level, markers of naive B cells
such as CD23 and CD44, as well as markers of bona fide
GC B cells such as CD10, CD38, and CD71. As sIgD1
CD381 B cells are found within GC exclusively, their in-
termediate phenotype is suggestive of a transitional stage of
maturation between follicular mantle naive B cells and
early GC B cells. Second, 29 out of 32 IgVH clonally inde-
pendent sequences are either in germline configurations
(17 sequences) or are poorly mutated (12 sequences) and
show no clear evidence for antigen-driven selection. More-
over, when sorted according to their size, .50% of the
medium-sized sIgM1IgD1CD381 B cells are germline or
low mutated, a characteristic expected for early GC B cells.
Third, in contrast to typical GC centroblasts which give
rise, after clonal expansion, to centrocytes, medium-sized
sIgM1IgD1CD381 B cells are not actively dividing as they
Figure 2. Cytological characterization of slgM1IgD1CD382 naive, slgD2CD381 GC, and slgM1IgD1CD381 B cells. (A) Giemsa staining of freshly
isolated three B cell subsets (31,000). (B) Expression of proliferation associated nuclear antigen Ki67 on freshly isolated B cell subsets (31,000). (C) Gi-
emsa staining of three B cell subsets after a 16 h culture, showing apoptotic figures in slgM1IgD1CD381 GC founder cells and in slgD2CD381 GC B
cells. The quantitation of apoptotic cells is shown in Table 2.568 Germinal Center Founder Cells
are Ki672. This suggests that these cells have not yet un-
dergone clonal expansion, a conclusion that is supported by
the lack of clonal relatedness between the IgVH sequences
of sIgM1IgD1CD381 B cells isolated from the same tonsil.
In conclusion, medium-sized, nonproliferating sIgM1IgD1
CD381 B cells are enriched for early GC B cells.
An important finding of the present study is the early
triggering of apoptosis program in sIgM1IgD1CD381 GC
founder cells, which happens before the onset of somatic
mutation. This early propensity to undergo apoptosis may
provide a mechanism for selection of cells bearing high af-
finity unmutated antigen receptors within GC. Conse-
Figure 3. Schematic representation of mutations in rearranged VH5-m sequences. Each line represents one VH5 sequence. VH5-2 sequences are un-
derlined. Leader region, CDR1, and CDR2 are indicated. Mutations present in the DJH regions are not shown. Mutations are represented by different
symbols.  d, replacement mutation; ), silent mutation; s, stop codon. (A and B) VH5-m sequences from slgM1IgD1CD382 B cells and
sIgM1IgD1CD381 B cells, respectively. The upper, middle, and lower groups of sequences represent three different tonsil samples. (C and D) VH5-m
sequences from medium-sized and large sIgM1IgD1CD381 B cells, respectively, that were isolated from the fourth tonsil.569 Lebecque et al.
quently, only the cells bearing antigen receptors with better
affinity will have the opportunity to undergo affinity matu-
ration. This hypothesis is supported by the finding that
many PNA1 mouse GC B cells, appearing during the first
10 d of primary response to NP (4-hydroxy-3-nitrophenyl)
contained selected IgV genes in germ line or low mutated
configurations (7, 36). In addition, this early propensity to
undergo apoptosis may also allow the immediate selection
of mutating cells (37). Consequently, the B cells entering
into GC have to mutate rapidly and efficiently in order to
survive.
The demonstration of sIgD on naive B cell derived GC
founder cells supports the hypothesis of Thorbecke et al.
(16) and Roes and Rajewsky (38) suggesting an auxiliary
receptor function for sIgD in antigen-mediated recruitment
of B cells into GC reaction and memory B cell formation.
This hypothesis was based on the following observations.
(a) sIgD are expressed on naive B cells 10 times more effi-
ciently than slgM (39) and bind antigen better than sIgM
due to their structural flexibility (40). These two character-
istics of sIgD may help naive B cells to colonize the net-
work of follicular dendritic cells when antigen become lim-
iting during GC development (38). (b) A subpopulation of
helper T cells bearing receptors for sIgD was found to play
an important role in enhancing T cell–dependent humoral
immune responses (41, 42). (c) In vivo injection of anti–
Figure 4. Identification of
IgM1IgD1 and IgM1IgD2 B
cells within GC: Double anti–
IgD (red) and anti–IgM (blue)
staining of a tonsil section. (A)
shows a secondary lymphoid fol-
licle that contains purple
IgD1IgM1 follicular mantle B
cells. Within the GC, IgM im-
mune complexes (blue) on follic-
ular dendritic cells can be ob-
served. In addition, scattered
purple IgM1IgD1 B cells and
blue IgM1IgD2 B cells can be
found (3100). (B) Shows a part
of this GC at 3200 magnifica-
tion.570 Germinal Center Founder Cells
mouse IgD dramatically increases, within 6 d, the volume
of GC in the spleen (43). (d) IgD-knock out mice displayed
a delayed affinity maturation of T cell–dependent antibody
responses (38) and a higher sensitivity to tolerance induc-
tion (44).
The present demonstration of sIgD on GC founder cells
also sets a limit to the concept of sIgD being an absolute
marker for naive resting B cells. This concept was essen-
tially based on the rapid loss of sIgD on naive B cells after
activation in vitro and in vivo (45, 46), and the apparent
lack of IgD expression in GC (21). However, consistent
with our present identification of sIgD1 proliferating GC
founder cells in vivo, sIgD1 proliferating B cells were ob-
served in long-term culture of CD40 activated human na-
ive B cells (47). Furthermore, the three VH-5m sequences
with more than 10 mutations showed evidence for antigen-
driven selection. These three mutated sIgM1IgD1CD381
B cells may either represent GC founder cells derived from
recirculating sIgM1IgD1 memory B cells or correspond to
GC centrocytes currently differentiating into sIgM1IgD1
memory B cells. Therefore, our present findings further
support the existence of sIgD1 memory B cells, demon-
strated in mouse adoptive transfer experiments a decade
ago (48, 49).
In conclusion, human GC founder cells have been iso-
lated as medium-sized, nonproliferating sIgM1IgD1CD381
B cells. Further study of this subpopulation of B cells
should lead to better understanding of the early events gov-
erning GC development.
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